In Israel, attention is being focused, to an unprecedented degree, onthe functioning of the sick funds. This is due to political factors and changes, including:
- the mid-1996 change in government, with Yehoshua Matza appointed Minister of Health; - changes at the top in the Ministry of Health and the Maccabi fund; - nearing the end of the National Health Insurance Law "transition period;" - the funds' worsening financial situation, especially the three smaller ones; and - negotiations/preparations for the 1997 budget in government and the Knesset.
There is a perceived need to fine-tune the NHIL to correct distortions and fill in missing elements, but as the system's severe financial instability continues, this may not be enough. In the absence of leadership and initiative, it is only a matter of time before a major political initiative is required (as with the NHIL).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze